Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Omega-3 Fatty Acids Block Macrophage Inflammatory Action

By LabMedica International staff writers
Posted on 13 Sep 2010
A possible dietary approach for ameliorating the symptoms of diabetes is based on omega-3 fatty acids, which recently have been shown to activate a critical inflammation suppressing signaling pathway.

Investigators at the University of California, San Diego (USA) worked with cells growing in culture and with a line of genetically engineered mice to study the relationship between omega-3 fatty acids and the G-protein receptor, GPR120. More...
GPR120, which is limited to fat tissue and macrophages, is a member of a large protein family many of whose members are drug targets.

The investigators reported in the September 3, 2010, issue of the journal Cell that the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) bind to and activate GPR120. Activated GPR120 triggers a molecular pathway that blocks the macrophages' inflammatory role.

They fed obese mice and mice genetically engineered to lack the gene for GPR120 (GPR120 knockout mice) a high fat diet with or without omega-3 fatty acid supplementation. The omega-3 treatment inhibited inflammation and enhanced systemic insulin sensitivity in the obese mice, but was without effect in GPR120 knockout mice.

"It is just an incredibly potent effect,” said senior author Dr. Jerrol Olefsky, professor of medicine at the University of California, San Diego. "The omega-3 fatty acids switch on the receptor, killing the inflammatory response. The receptor evolved to respond to a natural product – omega-3 fatty acids – so that the inflammatory process can be controlled. Our work shows how fish oils safely do this, and suggests a possible way to treating the serious problems of inflammation in obesity and in conditions like diabetes, cancer, and cardiovascular disease through simple dietary supplementation.”

Related Links:
University of California, San Diego


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.